Zirabev (bevacizumab)

pCPA File Number: 21105
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Colorectal Cancer / Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: